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Duration of Symptoms Resulting from Lumbar Disc
Herniation: Effect on Treatment Outcomes
Analysis of the Spine Patient Outcomes Research Trial (SPORT)
Jeffrey A. Rihn, MD, Alan S. Hilibrand, MD, Kristen Radcliff, MD, Mark Kurd, MD, Jon Lurie, MD, MS,
Emily Blood, MS, Todd J. Albert, MD, and James N. Weinstein, DO, MS
Investigation performed at the Rothman Institute, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania,
and Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
Background: The purpose of the present study was to determine if the duration of symptoms affects outcomes following
the treatment of intervertebral lumbar disc herniation.
Methods: An as-treated analysis was performed on patients enrolled in the Spine Patient Outcomes Research Trial
(SPORT) for the treatment of intervertebral lumbar disc herniation. Randomized and observational cohorts were combined.
A comparison wasmade between patients who had had symptoms for six months or less (n = 927) and those who had had
symptoms for more than six months (n = 265). Primary and secondary outcomes weremeasured at baseline and at regular
follow-up intervals up to four years. The treatment effect for each outcome measure was determined at each follow-up
period for the duration of symptoms for both groups.
Results: At all follow-up intervals, the primary outcome measures were significantly worse in patients who had had
symptoms for more than six months prior to treatment, regardless of whether the treatment was operative or nonoper-
ative. When the values at the time of the four-year follow-up were compared with the baseline values, patients in the
operative treatment group who had had symptoms for six months or less had a greater increase in the bodily pain domain
of the Short Form-36 (SF-36) (mean change, 48.3 compared with 41.9; p < 0.001), a greater increase in the physical
function domain of the SF-36 (mean change, 47.7 compared with 41.2; p < 0.001), and a greater decrease in the
Oswestry Disability Index score (mean change, –41.1 compared with –34.6; p < 0.001) as compared with those who had
had symptoms for more than six months (with higher scores indicating less severe symptoms on the SF-36 and indicating
more severe symptoms on the Oswestry Disability Index). When the values at the time of the four-year follow-up were
compared with the baseline values, patients in the nonoperative treatment group who had had symptoms for six months or
less had a greater increase in the bodily pain domain of the SF-36 (mean change, 31.8 compared with 21.4; p < 0.001), a
greater increase in the physical function domain of the SF-36 (mean change, 29.5 compared with 22.6; p = 0.015), and a
greater decrease in the Oswestry Disability Index score (mean change, 224.9 compared with 218.5; p = 0.006) as
compared with those who had had symptoms for more than six months. Differences in treatment effect between the two
groups related to the duration of symptoms were not significant.
Conclusions: Increased symptom duration due to lumbar disc herniation is related to worse outcomes following both
operative and nonoperative treatment. The relative increased benefit of surgery compared with nonoperative treatment
was not dependent on the duration of the symptoms.
Level of Evidence: Prognostic Level I. See Instructions for Authors for a complete description of levels of evidence.
Disclosure: One or more of the authors received payments or services, either directly or indirectly (i.e., via his or her institution), from a third party in
support of an aspect of this work. In addition, one or more of the authors, or his or her institution, has had a financial relationship, in the thirty-six months
prior to submission of this work, with an entity in the biomedical arena that could be perceived to influence or have the potential to influence what is written
in this work. Also, one or more of the authors has had another relationship, or has engaged in another activity, that could be perceived to influence or have
the potential to influence what is written in this work. The complete Disclosures of Potential Conflicts of Interest submitted by authors are always
provided with the online version of the article.
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ymptomatic herniation of the nucleus pulposus in the
lumbar spine affects 1% to 2% of the general population at
some time during their lives1,2. Symptomatic herniation of
the nucleus pulposus is most prevalent in men during the fourth
and fifth decades of life3. Although the presentation of symptoms
is variable, many patients recall an acute event that precipitated
low back pain associated with radicular unilateral or bilateral leg
pain. Leg pain resolves in 70% of patients within six weeks after
presentation4. Therefore, the treatment of herniation of the
nucleus pulposus generally begins nonoperatively and includes
education and counseling, nonsteroidal anti-inflammatory and
narcotic medication, physical therapy, and epidural injections.
According to most guidelines, surgery should be considered for
patients with persistent pain beyond a reasonable course of non-
operative therapy5.
Randomized trials from the past thirty years have dem-
onstrated the efficacy of the discectomy procedure for the treat-
ment of herniation of the nucleus pulposus6. More recent studies,
such as the Spine Patient Outcomes Research Trial (SPORT),
have further demonstrated the benefit of operative over non-
operative treatment for herniation of the nucleus pulposus7-12.
It is universally agreed that emergency surgery is rarely required.
There is no consensus, however, regarding the timing of elective
surgery for the treatment of lumbar disc herniation. Statements
in the literature include waiting anywhere from ‘‘an appropriate
amount of time’’ to twelvemonths after the onset of symptoms13-18.
The purpose of the present study was to use the SPORT database
to assess the effect of the duration of symptoms on outcomes
following the treatment of lumbar disc herniation. We hypoth-
esized that patients with a longer duration of pretreatment
symptoms have less favorable clinical outcomes than those with
a shorter duration of symptoms.
Materials and Methods
Study Design
SPORTwas conducted at thirteen multidisciplinary spine practices in elevenstates across the United States. The details of methods have been reported
previously
9,19-21
.
Patients
The human subject committees at each center approved the standardized pro-
tocol. Patients over the age of eighteen years who had radicular pain for at least six
weeks despite some form of nonoperative treatment, a positive nerve root tension
sign and/or neurological deficit, and a confirmatory cross-sectional imaging study
demonstrating intervertebral disc herniation at or caudad to L2, with the level
and side corresponding with the symptoms, were included in the study. Patients
with cauda equina syndrome, a progressive neurological deficit, malignant dis-
ease, scoliosis measuring >15, previous back surgery, and/or other established
contraindications to elective surgery were excluded.
Study Interventions
Patients were enrolled into either a randomized cohort or an observational cohort.
Those in the randomized cohort received computer-generated random treatment
assignments. Those in the observational cohort chose their treatment with their
physician. Patients in the operative treatment group underwent lumbar discec-
tomy with use of a traditional open posterior approach. Patients in the nonop-
erative treatment group were managed with ‘‘minimum nonsurgical treatment,’’
defined as active physical therapy, education and/or counseling with home
exercise instruction, and a nonsteroidal anti-inflammatory drug if tolerated.
Additionally, patients in the nonoperative treatment group could receive any
therapies above the minimum required protocol that were deemed appropriate
by their physician. Given the extensive crossover in the randomized cohort and
the similarity between baseline patient characteristics and outcomes when
comparing the randomized and observational cohorts, both of the cohorts were
combined for this study and an as-treated analysis was performed on the
combined cohorts.
Study Measures
The data for the present study were obtained from patient questionnaires that
were completed at baseline and at six weeks, three months, six months, one
year, two years, and four years after enrollment or surgery. The primary out-
come measures included the bodily pain and physical function domains of the
Short Form-36 (SF-36)
22
and the American Academy of Orthopaedic Surgeons
MODEMS (Musculoskeletal Outcomes Data Evaluation and Management
System) version of the Oswestry Disability Index (ODI)
23
. Secondary measures
included patient self-reported improvement, work status, and satisfaction with
current symptoms
1
. Symptom severity was measured with the Low Back Pain
Bothersomeness Index, the Sciatica Bothersomeness Scale, and the Leg Pain
Bothersomeness Scale
10,24
. The SF-36 scales and the ODI range from 0 to 100,
the Sciatica Bothersomeness Scale ranges from 0 to 24, and the Low Back Pain
Bothersomeness Index and the Leg Pain Bothersomeness Scale range from 0 to
6. Higher scores indicate more severe symptoms on the ODI, the Sciatica
Bothersomeness Scale, and the Leg Pain Bothersomeness Scale, whereas higher
scores indicate less severe symptoms on the SF-36.
Statistical Analysis
Differences in baseline characteristics were compared between patients who
had had symptoms for six months or less and those who had had symptoms for
more than six months. The primary analyses compared changes in the clinical
outcome measures from baseline as a function of the duration of symptoms
within each nonoperative or operative treatment arm. The duration of symp-
toms was based on the date of the onset of symptoms to the date of surgery for
patients in the operative treatment arm and was based on the date of onset of
symptoms to the date of enrollment in the study for those in the nonoperative
treatment arm. The treatment effect of surgery was calculated as the change in
outcome measure after operative treatment minus the change in outcome
measure after nonoperative treatment
25
.
Significance was defined as a p value of <0.05 on the basis of a two-sided
hypothesis test with no adjustment made for multiple comparisons. No ad-
justments were made because the analyses in the current study consisted of the
longitudinal assessment of different dimensions of outcomes (that is, symp-
toms, function, and disability) over time. The analyses were not multiple in-
dependent comparisons from which we were looking for a single significant
result, as would be implied by a Bonferroni or similar correction for multiple
comparisons. The various time points were not independently assessed but
were compared within the overall context of a longitudinal regression model
across three complementary domains of outcome.
Source of Funding
Funds were received from the National Institute of Arthritis and Musculo-
skeletal and Skin Diseases (U01-AR45444) and the Office of Research on
Women’s Health, the National Institutes of Health, and the National Institute of
Occupational Safety and Health, the Centers for Disease Control and Preven-
tion. The Multidisciplinary Clinical Research Center in Musculoskeletal Dis-
eases is funded by NIAMS (P60-AR048094). Funds were used for statistical
analysis and manuscript publication.
Results
Ofthe 1244 patients who were enrolled in the SPORTstudy,1192 patients had had data on the duration of symptoms;
of these, 927 patients had had symptoms for six months or less,
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and 265 had had symptoms for more than six months (Fig. 1).
The demographic and baseline characteristics are illustrated
in a table in the Appendix. Significant baseline differences
between the patients who had had symptoms for more than
six months and those who had had symptoms for six months
or less included a higher rate of depression (p = 0.005), a
higher proportion of patients who perceived that the problem
was getting worse (p = 0.002), and a greater proportion of
patients who had a preference for surgical treatment (p =
0.04) among those who had had symptoms for more than six
months. Otherwise, the demographic and baseline charac-
teristics were similar. There was no difference between the two
Fig. 1
Flowchart demonstrating the different study groups. SPORT = Spine Patient Outcomes Research Trial.
TABLE I Clinical Baseline Characteristics of ‘‘As Treated’’ Randomized Controlled Trial and Observational Cohorts Combined
Clinical Characteristic
Patients with Symptoms for
£6 Months* (N = 927)
Patients with Symptoms for
>6 Months* (N = 265) P Value
Pain radiation 903 (97%) 259 (98%) 0.94
Positive straight leg raise test
Ipsilateral 599 (65%) 151 (57%) 0.028†
Contralateral/bilateral 139 (15%) 49 (18%) 0.2
Neurological deficit
Any 715 (77%) 187 (71%) 0.034†
Reflexes (asymmetrical depression) 392 (42%) 89 (34%) 0.013†
Sensory (asymmetrical decrease) 480 (52%) 123 (46%) 0.14
Motor (asymmetrical weakness) 398 (43%) 103 (39%) 0.27
Herniation level 0.13
L2-L3/L3-L4 69 (7%) 19 (7%)
L4-L5 341 (37%) 115 (43%)
L5-S1 517 (56%) 130 (49%)
Herniation type <0.001†
Protruding 229 (25%) 93 (35%)
Extruded 621 (67%) 162 (61%)
Sequestered 77 (8%) 9 (3%)
Posterolateral herniation 722 (78%) 197 (74%) 0.26
*The values are given as the number of patients, with the percentage in parentheses. †Significant (p < 0.05).
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groups in terms of work status at baseline. In the operative
treatment group, 57% of patients who had had symptoms for six
months or less and 60% of those who had had symptoms for
more than six months had worked at either a full or part-time
job prior to surgery (p = 0.42). In the nonoperative treatment
group, 66% of patients who had had symptoms for six months
or less and 67% of those who had had symptoms for more than
six months had worked either a full or part-time job prior to
treatment (p = 0.11). There were no differences between the
patients who had had symptoms for six months or less and those
who had had symptoms for more than six months in terms of
baseline primary outcome measures (that is, SF-36 bodily pain
and physical function and Oswestry Disability Index).
Clinical baseline characteristics are reported in Table I.
Compared with patients who had had symptoms for more than
six months, a higher percentage of patients who had had symp-
toms for six months or less had a positive straight leg raise test
(8% difference; p = 0.028), neurological deficit (6% difference;
p = 0.034), asymmetric depressed lower extremity deep tendon
reflexes (8% difference; p = 0.013), and fewer protruding and
greater extruded or sequestered types of herniation on magnetic
resonance imaging (MRI) (p < 0.001). The details of operative
treatment are indicated in Table II. The operative time was eight
minutes greater for the patients who had had symptoms formore
than six months (p = 0.008). There were other slight differences
between the groups that did not reach significance.
TABLE II Operative Treatments, Complications, and Events of ‘‘As Treated’’ Randomized Controlled Trial and Observational
Cohorts Combined*
Patients with Symptoms
for £6 Months (N = 616)
Patients with Symptoms
for >6 Months (N = 182) P Value
Discectomy level (no. of patients)
L2-L3 12 (2%) 2 (1%) 0.68
L3-L4 21 (3%) 6 (3%) 0.84
L4-L5 238 (39%) 74 (41%) 0.54
L5-S1 357 (58%) 97 (53%) 0.45
Operative time† (min) 74.8 ± 35.2 83.2 ± 43.4 0.008‡
Blood loss† (mL) 60.8 ± 85 76.9 ± 144.9 0.061
Blood replacement (no. of patients)
Intraoperative replacement 4 (1%) 2 (1%) 0.9
Postoperative transfusion 0 (0%) 0 (0%) —
Length of stay† (d) 0.93 ± 0.9 1.1 ± 1 0.052
Intraoperative complications
(no. of patients)
Dural tear/spinal fluid leak 18 (3%) 6 (3%) 0.99
Nerve root injury 1 (0%) 1 (1%) 0.94
Other 3 (0%) 0 (0%) 0.8
None 595 (97%) 175 (96%) 0.96
Postoperative complications/events
(no. of patients)
Wound hematoma 4 (1%) 0 (0%) 0.62
Wound infection 15 (2%) 3 (2%) 0.73
Other 22 (4%) 5 (3%) 0.76
None 575 (94%) 172 (95%) 0.66
Additional operations
1-year rate 37 (6%) 9 (5%) 0.58
2-year rate 51 (8%) 12 (7%) 0.45
3-year rate 55 (9%) 15 (8%) 0.75
4-year rate 64 (10%) 17 (9%) 0.67
Recurrent disc herniation 37 (6%) 12 (7%)
Complication or other 17 (3%) 4 (2%)
New condition 8 (1%) 1 (<1%)
*The table includes complications for all patients in the study who had surgery, including ten patients who did not have enough follow-up data to
be included in the project’s data analysis set (represented by Figure1).†The values are given as the mean and the standard deviation.‡Significant
(p < 0.05).
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In the operative treatment group, patients who had had
symptoms for six months or less had significantly improved
primary outcome measures compared with those who had
had symptoms for more than six months. When the mea-
surements at each follow-up interval from one to four years
were compared with the baseline values, patients who had
had symptoms for six months or less had a greater increase in
the bodily pain domain of the SF-36 (mean change at four
years, 48.3 compared with 41.9; p < 0.001), a greater increase
in the physical function domain of the SF-36 (mean change
at four years, 47.7 compared with 41.2; p < 0.001), and a
greater decrease in the ODI score (mean change at four years,
241.1 compared with234.6; p < 0.001) in comparison with
those who had had symptoms for more than six months
(with higher scores indicating less severe symptoms on the
SF-36 and indicating more severe symptoms on the Oswestry
Disability Index) (Table III). In the operative treatment
group, the majority of secondary outcome measures, in-
cluding the Sciatica Bothersomeness Scale, satisfaction with
symptoms, self-rated health status, and working status, dem-
onstrated a significant benefit for patients who had had
symptoms for six months or less (see Appendix). The Leg Pain
Bothersomeness Scale and the Low Back Pain Bothersomeness
Index showed a definite trend toward greater improvement in
patients who had had symptoms for six months or less, but
the difference did not reach significance at the time of the four-
year follow-up (p = 0.051 and p = 0.084, respectively) (see
Appendix).
In the nonoperative treatment group, patients who had
had symptoms for six months or less also demonstrated im-
proved primary outcome measures compared with those who
had had symptoms for more than six months (Table III). When
the measurements at each follow-up interval from one to four
years were compared with the baseline values, patients who had
had symptoms for six months or less had a greater increase in
the bodily pain domain of the SF-36 (mean change at four
years, 31.8 compared with 21.4; p < 0.001), a greater increase in
the physical function domain of the SF-36 (mean change at
four years, 29.5 compared with 22.6; p = 0.015), and a greater
decrease in the ODI score (mean change at four years, –24.9
TABLE III Change from Baseline in Primary Outcome Measures for Operatively and Nonoperatively Managed Patients, According to
Duration of Symptoms, at One, Two, Three, and Four Years of Follow-up*
Change from Baseline
1 Year 2 Years 3 Years 4 Years
Operative treatment group
SF-36 bodily pain
Patients with symptoms for £6 months 46.3 ± 1.1 45.7 ± 1.1 46.5 ± 1.2 48.3 ± 1.2
Patients with symptoms for >6 months 40.2 ± 1.4 39.2 ± 1.4 40 ± 1.5 41.9 ± 1.5
P value <0.001 <0.001 <0.001 <0.001
SF-36 physical function
Patients with symptoms for £6 months 48.3 ± 1.1 47.1 ± 1.1 47.1 ± 1.1 47.7 ± 1.1
Patients with symptoms for >6 months 39 ± 1.4 39.1 ± 1.3 40.7 ± 1.4 41.2 ± 1.4
P value <0.001 <0.001 <0.001 <0.001
Oswestry Disability Index
Patients with symptoms for £6 months –40.3 ± 0.9 –39.9 ± 0.9 –40.4 ± 0.9 –41.1 ± 0.9
Patients with symptoms for >6 months –34.5 ± 1.1 –34.1 ± 1.1 –34 ± 1.1 –34.6 ± 1.2
P value <0.001 <0.001 <0.001 <0.001
Nonoperative treatment group
SF-36 bodily pain
Patients with symptoms for £6 months 30.7 ± 1.3 32.9 ± 1.3 32.9 ± 1.4 31.8 ± 1.4
Patients with symptoms for >6 months 22.7 ± 2.4 21.5 ± 2.5 22 ± 2.7 21.4 ± 2.8
P value 0.003 <0.001 <0.001 <0.001
SF-36 physical function
Patients with symptoms for £6 months 28.2 ± 1.2 30.3 ± 1.3 30.4 ± 1.3 29.5 ± 1.3
Patients with symptoms for >6 months 22 ± 2.3 22.8 ± 2.4 24.1 ± 2.6 22.6 ± 2.6
P value 0.013 0.005 0.025 0.015
Oswestry Disability Index
Patients with symptoms for £6 months –23.1 ± 1 –24.9 ± 1 –25.4 ± 1.1 –24.9 ± 1.1
Patients with symptoms for >6 months –16.4 ± 1.9 –17.4 ± 2 –17.1 ± 2.1 –18.5 ± 2.1
P value 0.001 <0.001 <0.001 0.006
*The values are given as the mean and the standard deviation.
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compared with –18.5; p = 0.006) in comparison with those
who had had symptoms for more than six months (with higher
scores indicating less severe symptoms on the SF-36 and indi-
cating more severe symptoms on the Oswestry Disability Index)
(Table III). The Sciatica Bothersomeness Scale, Leg Pain Both-
ersomeness Scale, Low Back Pain Bothersomeness Index, and
working status demonstrated a consistent benefit for the patients
who had had symptoms for six months or less (see Appendix).
The patients in the operative treatment group had better
outcomes than those in the nonoperative treatment group
at every follow-up time point for all primary outcomemeasures
(Fig. 2). The treatment effect, or the change from baseline
following operative treatment minus the change from base-
line following nonoperative treatment, was calculated sepa-
rately at each time point for the patients who had had
symptoms for six months or less and those who had had
Fig. 2
Line graph illustrating the change in primary outcomemeasures versus time for patients in the operative and nonoperative treatment groups who had had
symptoms for six months or less or for more than six months.
TABLE IV Treatment Effect After Surgery for Primary Outcome Measures According to Duration of Symptoms
Mean Treatment Effect (95% CI*)
Outcome Scale 1 Year 2 Years 3 Years 4 Years
SF-36 bodily pain
Patients with symptoms for £6 months 15.6 (12.1 to 19) 12.8 (9.3 to 16.3) 13.6 (10 to 17.3) 16.5 (12.8 to 20.3)
Patients with symptoms for >6 months 17.5 (12.1 to 22.9) 17.7 (12.2 to 23.2) 18 (12.1 to 23.9) 20.6 (14.5 to 26.6)
P value 0.55 0.14 0.21 0.26
SF-36 physical function
Patients with symptoms for £6 months 20 (16.8 to 23.3) 16.8 (13.5 to 20.1) 16.8 (13.4 to 20.2) 18.2 (14.7 to 21.7)
Patients with symptoms for >6 months 17 (12 to 22) 16.3 (11.2 to 21.4) 16.5 (11 to 22.1) 18.6 (13 to 24.2)
P value 0.31 0.86 0.94 0.91
Oswestry Disability Index
Patients with symptomsfor £6 months 217.2 (219.9 to 214.6) 215 (217.7 to 212.3) 25 (217.8 to 212.2) 216.3 (219.2 to 213.4)
Patients with symptoms for >6 months 218.1 (222.2 to 214) 216.7 (220.8 to 212.5) 216.9 (221.4 to 212.4) 216.1 (220.6 to 211.6)
P value 0.72 0.5 0.46 0.96
*CI = confidence interval.
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symptoms for more than six months to determine if the du-
ration of symptoms influenced the relative effectiveness of
operative intervention as compared with nonoperative in-
tervention (Table IV) (see Appendix). The treatment effect for
all primary and secondary outcome measures was similar in
patients who had had symptoms for six months or less and
those who had had symptoms for more than six months,
indicating that operative treatment offers similar advantages
over nonoperative treatment, regardless of the duration of
symptoms (Fig. 3).
A post hoc power analysis was performed to ensure that
our study was sufficiently powered. We based the power analysis
around one of the primary outcome variables in the operative
treatment population, the SF-36 bodily pain subscale. In order
to show a difference between patients who had had symptoms
for six months or less and those who had had symptoms for
more than six months prior to operative treatment, SF-36 bodily
pain subscales in one group would have to exceed those in the
other by at least the minimum clinically important difference.
To maintain a conservative estimate of the power of the study,
the minimum clinically important difference was selected on
the basis of the study by Lauridsen et al.26, which demonstrated
an increasing minimum clinically important difference with
improved baseline scores up to a maximum value for the min-
imum clinically important difference of 5 on the SF-36 bodily
pain subscale. On the basis of this minimum clinically important
difference, the observed difference of 6.4 points between patients
with symptoms for six months or less and those with symptoms
for more than six months before operative treatment, and the
observed standard deviation of approximately 1.5 points, the
power of the study approaches 1. This is an expected result,
both because of the large study size and because the difference
between these groups in terms of the SF-36 bodily pain sub-
scale exceeded the minimum clinically important difference.
Discussion
The authors of previous observational studies have identi-fied worse outcomes in patients with a longer duration of
pretreatment symptoms and have recommend earlier surgical
intervention27-31. Nygaard et al. found worse self-reported
outcomes in patients who had had leg pain for more than eight
months in a prospective study of 132 consecutive patients27.
Jansson et al., in a prospective follow-up study of 283 patients
who underwent surgery for the treatment of lumbar disc her-
niation, showed that a duration of pain of more than six months
was a risk factor for a worse health-related quality of life as
determined with the EuroQol-5D measurement tool28. Ng and
Sell, in a prospective cohort study of 113 consecutive patients
with lumbar disc herniation, determined that patients who had
had symptoms for more than twelve months had significantly
worse outcomes in comparison with patients who had had
symptoms for less than twelve months before operative treat-
ment29. Jo¨nsson investigated patient-related factors predicting
the outcome after decompressive surgery in a study of 120
patients with lumbar disc herniation30. A duration of sciatica of
more than six months and a long absence from work had sig-
nificant negative influence on the two-year surgical outcome.
Recently, Peul et al.32 performed a large, multicenter
randomized trial involving 283 patients with sciatica and
lumbar disc herniation in which early surgery (that is, within
Fig. 3
A comparison of the treatment effects for each of the three primary outcomemeasures between patients who had had symptoms for sixmonths or less and
those who had had symptoms for more than six months. The p values comparing treatment effects between the groups were not significant.
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two weeks) was compared with a six-month period of non-
operative treatment followed by surgery if needed after this
period of nonoperative treatment. All patients had symptoms
for six to twelve weeks prior to enrollment. Early surgery of-
fered significant benefits over nonoperative treatment in the
early follow-up period, with the maximum benefit achieved
between eight to twelve weeks after enrollment. At one year and
two years33,34 after randomization, however, there were no sig-
nificant differences between the two groups in terms of the
primary outcome measures. It should be noted that, during the
first year of the study, 39% of the patients who had been ran-
domized to six months of nonoperative treatment crossed over
and underwent surgery at an average of 14.6 weeks after en-
rollment. It should also be noted that the authors chose to
perform an intent-to-treat analysis of their data. In an intent-
to-treat analysis, this substantial crossover may lead to an un-
derestimation of the benefits of surgical treatment. According
to the authors, patients who had unsuccessful nonoperative
treatment and underwent late surgery had similar improve-
ment at one and two years as compared with patients who were
allocated to early surgery35. These findings suggest that there is
no downside to attempting nonoperative treatment prior to
performing surgery.
Similar to many of the previously published studies, the
current study suggests that patients who have symptoms of a
herniated lumbar disc for more than six months do not have
clinical results that are as good as those for patients who have
symptoms for six months or less prior to the initiation of any
formal treatment program. In the operative treatment group,
patients who had had symptoms for more than six months had
significant improvements over baseline. However, the im-
provements were not as great as those achieved in the opera-
tively managed patients who had had symptoms for six months
or less. Similarly, in the nonoperative treatment group, patients
who had had symptoms for more than six months had sig-
nificant improvements over baseline, but the improvements
were not as great as those seen in those who had had symptoms
for six months or less. As indicated by the reported treatment
effects, operative treatment provided a benefit over nonoper-
ative treatment at all follow-up time intervals for all primary
outcome measures. There was no significant difference in the
calculated treatment effects between the two groups, suggesting
that surgical treatment offers similar advantages over nonop-
erative treatment, regardless of the duration of symptoms.
Although they may not have done as well as patients with a
shorter duration of symptoms, those who had had symptoms
for more than six months had a better outcome following
surgery as compared with following nonoperative treatment.
Similarly, consistent with the findings of Peul et al.32-34, no
greater advantage is gained with operative over nonoperative
treatment when performed for patients with shorter duration
of symptoms. This information can be helpful when counseling
patients on the options for the treatment of symptomatic
lumbar disc herniation.
The present study had limitations. Differences in baseline
data between the group of patients who had had symptoms for
six months or less and the group of patients who had had
symptoms for more than six months may have affected the
results. These differences included the type of disc herniation,
the presence of neurological deficit, the operative time, the
percentage of patients who reported depression, the percentage
of patients who perceived that the problem was getting worse,
and the percentage of patients who had a preference for surgical
treatment. Several of these variables have been shown in previ-
ous studies to have an effect on the outcome of lumbar discec-
tomy36-44. Although the SPORT investigation was not powered
specifically to detect differences between subgroups on the basis
of the duration of symptoms, we did detect significant differ-
ences between the patients who had symptoms for six months or
less and those who had had symptoms formore than sixmonths.
However, it is possible that there may be additional clinically
relevant differences between the subgroups in terms of baseline
characteristics or outcomes that we were not able to detect.
Future investigations might address the role of potential con-
founding variables, such as patient expectations, the perception
of symptomatic improvement, and depression/mental status,
in determining patient outcomes.
Appendix
Tables showing the baseline characteristics of the cohorts,
the change from baseline in terms of secondary outcome
measures for the operatively and nonoperatively managed
patients, and the treatment effect of surgery in terms of sec-
ondary outcome measures are available with the online version
of this article as a data supplement at jbjs.org n
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